As shown in
, SPP (10-500 nM) activated ERK activity in a dose-dependent manner in HUVEC. This response was inhibited completely by pretreating cells with pertussis toxin and PD98059, indicating that this activity is dependent on the G i protein and MAP kinase kinase. Complete inhibition by pertussis toxin suggests that most of the SPP effects on MAP kinase are mediated by EDG-1. 3C ) into discontinuous script was expressed at a much lower level and the EDG-5 mRNA was undetectable ( Figure 1A ). EDG-1 expression structures at cell-cell contact regions, suggesting that SPP induces the formation of adherens junctions. Treatwas estimated to be 16-fold more abundant than EDG-3. In contrast, EDG-3 is the predominant SPP receptor isoment with related lipids (sphingosine, sphingomyelin, ceramide, ceramide-1-phosphate) that do not interact type in human embryonic kidney (HEK)293 cells.
Regulation of Adherens Junction
We next tested, by sensitive functional assays, the with SPP receptors had no effect (data not shown). Also, direct microinjection of SPP (ranging from 500 nM to presence of G i -and G q -coupled SPP receptors in HU-VEC. As shown in Figure 1B , SPP induced a robust 500 M) into the cytoplasm did not increase the immunoreactivity of VE-cadherin and catenins at cell-cell calcium response in endothelial cells, which was inhibited approximately 90% by pertussis toxin, whereas the junctions (see Supplemental Data). Formation of mature adherens junctions requires ho-G q -coupled ATP receptor response was not pertussis toxin sensitive. These data suggest that EDG-1, a mophilic binding of intercellular cadherins, association with cytoplasmic polypeptides, and attachment to the G i -coupled SPP receptor, is responsible for the majority of SPP-induced calcium responses in HUVEC. The pertuscytoskeleton, which ultimately results in the partitioning of cadherin molecules into the detergent-insoluble fracsis toxin-resistant component may be due to the activity of EDG-3. Secondly, we utilized the SPP-induced extration (Yap et al., 1997) . Fractionation of HUVEC cell lysates showed that SPP-induced, in a dose-and cellular signal-activated kinase (ERK) activation assay. in a mutually exclusive manner in adherens junctional complexes.
Requirement for Rac and Rho GTPases in SPPInduced Adherens Junction Assembly
Next, we examined the subcellular localization of Rac and Rho in HUVEC before and after SPP treatment. Interestingly, treatment with SPP for 10-30 min resulted in significant redistribution of Rac to the cell-cell contact areas, whereas subcellular localization of Rho was not altered ( Figure 3A) . Tiam1, a guanine nucleotide exchange factor specific for Rac (Michiels et al., 1995) , was also translocated to cell-cell contact areas ( Figure  3A) . Double immunostaining exhibited an overlapping pattern between Tiam1 and ␤-catenin after SPP treatment.
To determine if Rho and Rac small GTPases are required for SPP-induced adherens junction assembly, C3 exoenzyme and dominant-negative N17Rac polypeptide were microinjected into HUVEC cells. As shown in Figures 3B and 3C , microinjection of C3 and N17Rac dramatically diminished SPP-induced VE-cadherin immunoreactivity at cell-cell junctions. Similar results were observed for ␤-catenin immunoreactivity (see Supplemental Data). Neither the injection of FITC-mouse IgG nor the inactivation of the heterotrimeric G i protein by treatment or microinjection of pertussis toxin inhibited VE-cadherin and ␤-catenin localization at cell-cell junc- specificity. Likewise, EDG-3 antisense PTO only inhibited the respective cRNA for EDG-3. These data suggest that the EDG-1 and -3 PTOs are specific inhibitors of respective receptor expression. These reagents were time-dependent manner, an increase in the amount of VE-cadherin in the Triton X-100 insoluble fraction; howmicroinjected into the cytoplasm of HUVEC to block the expression of EDG-1 and -3 receptors, and SPP-induced ever, the overall level of protein was not altered ( Figure  2B ). Consistent with the immunofluorescence data, the VE-cadherin assembly into cell-cell junctions was analyzed. As shown in Figure 4B and Table 1 , both EDG-1 increase of VE-cadherin in Triton X-100 insoluble fractions peaked at 1-2 hr following SPP treatment.
and -3 antisense PTOs inhibited the SPP-induced VEcadherin localization at cell-cell junctions. In contrast, To directly show that SPP signaling in endothelial cells regulates adherens junction assembly, a coimmunoneither the complementary nor the scrambled sequence of EDG-1 and -3 oligonucleotides inhibited VE-cadherin precipitation experiment was conducted. As shown in Figure 2C , SPP significantly increased the ␣-catenin and assembly significantly. Furthermore, antisense EDG-1 PTO attenuated the formation of cortical actin structures VE-cadherin polypeptides in the ␥-and ␤-catenin immunoprecipitates. In agreement with previous findings in HUVEC, which are known to be induced by the Rac pathway ( Figure 4C ). In contrast, formation of stress (Hinck et al., 1994), ␤-catenin and ␥-catenin are found gesting that a G i -dependent SPP signaling pathway is inhibited in the presence of pertussis toxin and PD98059 ( Figure 5F ). Also, antisense EDG-1 PTO treatment reessential ( Figure 5B ). It is known that a critical function of angiogenic factors is to promote endothelial cell survival duced the ability of SPP to block ceramide-induced apoptosis (44% Ϯ 4%) whereas sense EDG-1 PTO or (Ilan et al., 1998; Satake et al., 1998). Indeed, SPP, in a dose-dependent manner (10-500 nM), significantly proantisense EDG-3 or EDG-5 PTO did not have significant effects (Ͻ5%). These data strongly suggest that EDGtected cells from apoptosis induced by C 2 -ceramide ( Figures 5E and 5F ). This effect was also seen when 1/G i /ERK pathway mediates SPP-induced endothelial cell survival. growth factor withdrawal and 15-deoxy-⌬ 12,14 prostaglandin J 2 were used as apoptotic stimuli (data not
The Rho inhibitor C3 exoenzyme abolished SPPinduced morphogenesis of endothelial cells ( Figure 5B) . shown). This cytoprotective effect of SPP is completely In addition, SPP protects endothelial cells potently from apoptosis induced by ceramide, 15d-PGJ 2 and growth factor withdrawal. These treatments are known to induce caspase-dependent apoptosis (Cuvillier et al., 1996; Bishop-Bailey and Hla, 1999). SPP was previously shown to protect monocytic cells from ceramide induced apoptosis, which was interpreted to occur via a second messenger action (Cuvillier et al., 1996) . In this study, we show that nanomolar concentrations of extracellular SPP prevented endothelial cell apoptosis. This effect was completely blocked by pertussis toxin and the MAP kinase kinase inhibitor PD98059, suggesting that SPP signaling via the G i pathway is involved. Indeed, antisense PTO for EDG-1 but not EDG-3 attenuated the survival function of SPP. These data imply that SPP may be an important platelet-derived survival factor for endothelial cells.
SPP induced endothelial cell morphogenesis into capillary-like networks in the matrigel model of in vitro angiogenesis. This was potently inhibited by VE-cadherin extracellular domain antibodies, pertussis toxin, and C3 exotoxin. In addition, EDG-1 and EDG-3 antisense PTO The following 18-mer phosphothioate oligonucleotides (PTO) were were washed with ice-cold PBS, fixed, and immunofluorescence analysis with various antibodies was conducted as follows: VEsynthesized to block the expression of EDG-1 and EDG-3 receptors: antisense EDG-1, 5Ј-GAC GCT GGT GGG CCC CAT-3Ј and 5Ј-GCT cadherin (1.25 g/ml, Transduction Labs; 1 g/ml Santa Cruz), ␤-catenin (1.25 g/ml, Transduction Labs), ␥-catenin (1.25 g/ml,
GGT GGG CCC CAT GGT-3Ј; sense EDG-1, 5Ј-ATG GGG CCC ACC AGC GTC-3Ј; scrambled EDG-1, 5Ј-TGA TCC TTG GCG GGG CCG-3Ј; Transduction Labs), ␣-catenin (1.25 g/ml, Transduction Labs),
